Sunflower Pharmaceutical Group Co (SZSE:002737) ROCE % : 8.51% (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Sunflower Pharmaceutical Group Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sunflower Pharmaceutical Group Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 8.51%.

Sunflower Pharmaceutical Group Co ROCE % Historical Data

The historical data trend for Sunflower Pharmaceutical Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunflower Pharmaceutical Group Co ROCE % Chart

Sunflower Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

20.16

19.46

21.68

23.61

26.63

Sunflower Pharmaceutical Group Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															17.67	24.46	24.59	22.87	8.51

Sunflower Pharmaceutical Group Co ROCE % Calculation

Sunflower Pharmaceutical Group Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	1360.735	/	( ( (7031.747 - 2175.369)	+	(6881.913 - 1519.915) )	/ 2 )
	=	1360.735	/	( (4856.378	+	5361.998)	/ 2 )
	=	1360.735	/	5109.188
	=	26.63 %

Sunflower Pharmaceutical Group Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	421.72	/	( ( (6250.954 - 1290.159)	+	(5931.721 - 980.677) )	/ 2 )
	=	421.72	/	( ( 4960.795	+	4951.044 )	/ 2 )
	=	421.72	/	4955.9195
	=	8.51 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Sunflower Pharmaceutical Group Co (SZSE:002737) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sunflower Pharmaceutical Group Co ROCE % Related Terms

Thank you for viewing the detailed overview of Sunflower Pharmaceutical Group Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunflower Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunflower Pharmaceutical Group Co Ltd (SZSE:002737) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Welcome Road, 18 East Lake Road, Harbin High-Tech Industrial Development Zone, Harbin, Heilongjiang, CHN

Website

http://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co Ltd is engaged in pharmaceutical manufacturing, marketing, and scientific research. The company's product profile include Honeysuckle, Weikangling Granules, Autumn pear moisturizing cream, Vitamin AD drops, Pediatric paracetamol granules, Jianweixiaoshi tablets, Pediatric Chai Gui Antipyretic Granules, Pediatric cough syrup, Kang Fu anti-inflammatory suppository, Xiangsha Yangwei Pills, and others.

Executives

Zhou Jian Zhong	Executives
Liu Tian Wei	Director
Guan Yu Xiu	Director
Wu Guo Xiang	Executives
Ren Jing Shang	Directors, executives
Guan Yan Bin	Directors, executives
Wan Yun Guo	Executives
Tian Yan	Secretary Dong
Tan Chang	Executives
Zhang Quan	Director
Xu Qing Fen	Supervisors
Jiang Feng He	Supervisors
Wu Shu Hua	Director
Guan Yan Ling	Director

Sunflower Pharmaceutical Group Co Headlines

No Headlines